AR026768A1 - MOLECULES SIMILAR TO ANTAGONISTS OF INTERLEUKIN-1 RECEIVERS AND USES OF THE SAME - Google Patents

MOLECULES SIMILAR TO ANTAGONISTS OF INTERLEUKIN-1 RECEIVERS AND USES OF THE SAME

Info

Publication number
AR026768A1
AR026768A1 ARP000106550A ARP000106550A AR026768A1 AR 026768 A1 AR026768 A1 AR 026768A1 AR P000106550 A ARP000106550 A AR P000106550A AR P000106550 A ARP000106550 A AR P000106550A AR 026768 A1 AR026768 A1 AR 026768A1
Authority
AR
Argentina
Prior art keywords
interleukin
antagonists
receivers
same
polypeptides similar
Prior art date
Application number
ARP000106550A
Other languages
Spanish (es)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR026768A1 publication Critical patent/AR026768A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Abstract

La presente provee polipéptidos similares a antagonistas de receptores de interleukin-1 y moléculas de ácido nucleico que los condifican. La presentetambién provee agentes selectivos de enlace, vectores, células huésped y métodos para producir polipé tidos similares a antagonistas de receptores deinterleukin-1. La presente provee adicionalmente composiciones farmacéuticas y métodos para el diagnostico, tratamiento, mejora y/o prevencion de enfermedades,desordenes y condiciones asociadas con polip éptidos similares a antagonistas de receptores de interleukin-1.This provides polypeptides similar to antagonists of interleukin-1 receptors and nucleic acid molecules that condition them. The present also provides selective binding agents, vectors, host cells and methods for producing polypeptides similar to deinterleukin-1 receptor antagonists. This further provides pharmaceutical compositions and methods for the diagnosis, treatment, improvement and / or prevention of diseases, disorders and conditions associated with polypeptides similar to interleukin-1 receptor antagonists.

ARP000106550A 1999-12-10 2000-12-11 MOLECULES SIMILAR TO ANTAGONISTS OF INTERLEUKIN-1 RECEIVERS AND USES OF THE SAME AR026768A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17019199P 1999-12-10 1999-12-10
US18805300P 2000-03-09 2000-03-09
US19452100P 2000-04-04 2000-04-04
US19591000P 2000-04-10 2000-04-10
US72458300A 2000-11-28 2000-11-28

Publications (1)

Publication Number Publication Date
AR026768A1 true AR026768A1 (en) 2003-02-26

Family

ID=27538813

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106550A AR026768A1 (en) 1999-12-10 2000-12-11 MOLECULES SIMILAR TO ANTAGONISTS OF INTERLEUKIN-1 RECEIVERS AND USES OF THE SAME

Country Status (6)

Country Link
EP (1) EP1246844A1 (en)
JP (1) JP3842647B2 (en)
AR (1) AR026768A1 (en)
AU (1) AU779534B2 (en)
MX (1) MXPA02005775A (en)
TW (1) TWI283683B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018106956A2 (en) 2016-12-07 2018-06-14 University Of Florida Research Foundation, Incorporated IL-1RA CDNAs
CN113940308A (en) * 2021-04-28 2022-01-18 重庆腾达牧业有限公司 Dazu black goat breeding house feeding management method

Also Published As

Publication number Publication date
EP1246844A1 (en) 2002-10-09
AU779534B2 (en) 2005-01-27
TWI283683B (en) 2007-07-11
JP2003518371A (en) 2003-06-10
JP3842647B2 (en) 2006-11-08
MXPA02005775A (en) 2003-10-14
AU1945001A (en) 2001-06-18

Similar Documents

Publication Publication Date Title
BRPI0413563A (en) compounds and compositions as inhibitors of tyrosine kinase receptor activity
EA200200647A1 (en) Β2-adrenergic receptor agonists
FI963101A0 (en) Use of anti-TNF antibodies as drugs for the treatment of diseases in which serum interleukin-6 levels are elevated
AR029199A1 (en) DERIVATIVES OF ADENOSINA N6 HETEROCICLICO 5'-TIO- SUBSTITUTES AGONIST A1 PARTIAL OR TOTAL, ITS USES, AND THE PHARMACEUTICAL COMPOSITIONS
WO2000015231A8 (en) Adenosine a3 receptor modulators
BR0309875A (en) methods and compositions for treating peripheral nervous system disorders and novel compounds useful therefor
BRPI0512674A (en) compounds and compositions as modulators of steroid hormone nuclear receptors
EA200101019A1 (en) GLUCOCORTICOID RECEPTOR MODULATORS
AR002705A1 (en) A NEW INDOLINA COMPOUND, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
MA29088B1 (en) INDAZOLE-CARBOXAMIDE COMPOUNDS.
BR0207952A (en) Modulators of chemokine receptor activity
BR0315234A (en) Indole derivatives as beta-2 agonists
UY24560A1 (en) PIRIMIDINE ARYL DERIVATIVES USEFUL AS SELECTIVE 5HT2B ANTAGONISTS
AR030236A1 (en) MOLECULES SIMILAR TO IL-17 AND USES OF THE SAME
BRPI0517015A (en) compounds and compositions as inhibitors of cannabinoid receptor 1 activity
MX9301348A (en) NEW COMPOUNDS THAT HAVE PHARMACOLOGICAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM.
AR030554A1 (en) SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME
ES2196063T3 (en) USE OF PROGESTERONE COMPETITIVE ANTAGONIST AGENTS FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DYSFUNCTIONAL UTERINE HEMORRAGIES.
GT200300294A (en) INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES AND PROCEDURES FOR USE
WO2005030678A3 (en) AMINO-SUBSTITUTED ETHYLAMINO β2 ADRENERGIC RECEPTOR AGONISTS
BRPI0409436A (en) 4-phenylpiperidine compounds and their use as opioid receptor modulators
BRPI0413013A (en) compound, its salts, solvates, and pharmaceutically functional derivatives, pharmaceutical composition, use of a compound, and methods for the treatment or prophylaxis of conditions or disorders, and diseases
CR6581A (en) PIRROLCARBOXAMIDAS CAST, GABA CEREBRAL RECEPTORS
ECSP003707A (en) DIAZEPANES
WO2003087338A3 (en) Her-2 receptor tyrosine kinase molecules and uses thereof

Legal Events

Date Code Title Description
FB Suspension of granting procedure